The Royal Dames of Cancer Research, Inc., has awarded a $1 million gift to Nova Southeastern University (NSU) to accelerate NSU's next phase of cancer research focused on developing therapies and ...
Cancer remains one of the most formidable challenges in modern medicine — but it is also one of the most dynamic frontiers of pharmaceutical innovation. Over the past decade, oncology has become the ...
The future of medicine has arrived, and it brings with it a lot of confusion. From tests to supplements, dietary and exercise advice, it is often difficult to know how to use new medical ...
News-Medical.Net on MSN
Dual-positive hybrid cells linked to shorter survival in advanced breast cancer
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast ...
Pierre Fabre Pharmaceuticals, Inc., announces the U.S. Food and Drug Administration (FDA) has agreed to Type A meeting for the biologic license application for tabelecleucel, an allogeneic T-cell ...
MAFS star Mel Schilling has revealed her ‘light is starting to fade quickly’ as she shared that her cancer has spread to her brain. The 54-year-old dating coach appears on both the ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results